Results 121 to 130 of about 8,174 (197)

HCV cure without interferon [PDF]

, 2014
Marc Bourlière
core   +1 more source

Identification of Candidate Inhibitors to SARS-CoV-2's Enzymes and Potential Disruptors of Its Structural Proteins' Interactions. [PDF]

Adv Biomed Res
Mohammadian A, Jadaliha M, Imanpour A, Pourvali Moghadam H, Jahangir A.   +4 more
europepmc   +1 more source

Repurposing antiviral agents against mucormycosis. [PDF]

PLoS One
Khan AA, AlKashef NM, Seleem MN.
europepmc   +1 more source

Genetic Characterization of Hepatitis C Virus Among People Who Use Crack Cocaine: A Study Conducted on the Brazilian Amazon Coast. [PDF]

Pathogens
Heymbeeck JAA, do Nascimento WL, Freitas MCS, de Sousa Rocha L, Costa FF, de Queiroz JPQ, Simeone D, Martins LC, Machado LFA, Fischer B, Kupek E, Oliveira-Filho AB.   +11 more
europepmc   +1 more source

Safety and efficacy of different therapeutic regimens in Egyptian adults with moderate COVID-19 infection (EVEREST): a real-world retrospective study. [PDF]

Sci Rep
Abdel-Salam Elgohary M, Hamza N, Ali A, Zaher Abdel-Rahman R, Thabet Elnagar M, Emam Mohamed M, Seadawy MG, Zenhom Abdelfatah M, Taha NA, Rauof M, El-Bouseary MM.   +10 more
europepmc   +1 more source

The effect of HFE gene mutation and iron overload on sustained virological response in Egyptian chronic hepatitis C patients treated with daclatasvir and sofosbuvir. [PDF]

Korean J Intern Med
Kodsi EM, Ismail H, Issa R, Elshaarawy A, Sakr MA, Shehata EL, Issak ER.   +6 more
europepmc   +1 more source

Specific, highly sensitive and simple spectrofluorimetric method for quantification of daclatasvir in HCV human plasma patients and in tablets dosage form

Open Chemistry, 2019
Ali Ramadan, Elsutohy Mohamed M
doaj   +1 more source

Sensitive RP-HPLC method with fluorimetric detection for concurrent quantification of emtricitabine, Daclatasvir and Ledipasvir in human urine. [PDF]

Sci Rep
Youssef AA, Magdy N, Hussein LA, El-Kosasy AM.   +3 more
europepmc   +1 more source

Eight weeks of sofosbuvir/velpatasvir for genotype 3 hepatitis C in previously untreated patients with significant (F2/3) fibrosis [PDF]

, 2020
Barclay, Stephen T., Boyle, Alison, Datta, Shouren, Heydtmann, Mathis, Marra, Fiona, Peters, Erica, Priest, Matthew, Ritchie, Trina   +7 more
core   +3 more sources

Evaluating long-term outcomes of direct-acting antiviral therapy in chronic hepatitis C: A retrospective study. [PDF]

Medicine (Baltimore)
Sung BR, Shim SG, Kim KM, Lee JW, Kim JY, Lee BK, Jun CH, Kwan BS.   +7 more
europepmc   +1 more source